SCHEMBL30200341

SCHEMBL30200341

CC(=O)/C=C/C1C(C)(O)C(OC(C)=O)C(O)C2C(C)(C)CCCC21C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN2 P17706 1/20 0.38
PTPN1 P18031 1/20 0.38
MAPK1 P28482 5/20 0.35
CYP3A4 P08684 4/20 0.35
TSHR P16473 2/20 0.35
KMT2A Q03164 2/20 0.35
GMNN O75496 1/20 0.35
BLM P54132 1/20 0.35
PMP22 Q01453 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
CYP2D6 P10635 1/20 0.35
NFKB1 P19838 1/20 0.35
HIF1A Q16665 1/20 0.35
NR1I2 O75469 1/20 0.35
CHRM2 P08172 1/20 0.35
ABCB1 P08183 1/20 0.35
HTR1A P08908 1/20 0.35
ADRA2A P08913 1/20 0.35
SLC2A1 P11166 1/20 0.35
HTR2A P28223 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3678939 0.84 PTPN2 (0.41) PTPN2PTPN1MAPK1CYP3A4TSHR
SCHEMBL3681475 0.84 PTPN2 (0.44) PTPN2PTPN1MAPK1CYP3A4KMT2A
SCHEMBL30498601 0.73 MAPT (0.38) MAPK1CYP3A4TSHRKMT2AGMNN
SCHEMBL3680334 0.71 PTPN1 (0.47) PTPN2PTPN1NFKB1HIF1ATRPM2
SCHEMBL18531567 0.70 ALDH1A1 (0.32) PTPN2PTPN1CYP3A4TSHRTP53
SCHEMBL17342675 0.70 ALDH1A1 (0.32) PTPN2PTPN1CYP3A4TSHRTP53
SCHEMBL20245300 0.69 PTPN2 (0.48) PTPN2PTPN1UGT2B7
SCHEMBL30200170 0.68 UGT2B7 (0.32) MAPK1CYP3A4TSHRKMT2ANR1I2
8-Hydroxy-15,16-Bisnor-11-Labden-13-One SCHEMBL20640825 0.65 PTPN2 (0.55) PTPN2PTPN1CYP3A4TSHRKMT2A
SCHEMBL29934831 0.65 TRPC6 (0.32) MAPK1CYP3A4TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4401714-A1 ORAL COMPOSITIONS WITH PLANT MATTER EXTRACTS AND METHODS OF MAKING THE SAME Nulixir Inc. (US) 2024-07-24 EP claimed
EP-4401713-A1 ALIMENTARY-RELATED PARTICLES, PRODUCTION METHODS, AND PRODUCTION APPARATUS Nulixir Inc. (US) 2024-07-24 EP claimed
US-20230157973-A1 ORAL COMPOSITIONS WITH PLANT MATTER EXTRACTS AND METHODS OF MAKING THE SAME Nulixir Inc. 2023-05-25 US claimed
US-20230149829-A1 ORAL COMPOSITIONS OF PLANTS THROUGH A DOUBLE EXTRACTION SYSTEM AND METHODS OF MAKING THE SAME Nulixir Inc. 2023-05-18 US claimed
US-20230111238-A1 STABLE COMPOSITIONS OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME Nulixir Inc. 2023-04-13 US claimed
US-20230111756-A1 STABLE FORMULATIONS OF PLANTS EXTRACTS AND METHODS OF MAKING THE SAME Nulixir Inc. 2023-04-13 US claimed
WO-2023043854-A1 ALIMENTARY-RELATED PARTICLES, PRODUCTION METHODS, AND PRODUCTION APPARATUS Nulixir Inc. (US) 2023-03-23 WO claimed
WO-2023043855-A1 ORAL COMPOSITIONS WITH PLANT MATTER EXTRACTS AND METHODS OF MAKING THE SAME Nulixir Inc. (US) 2023-03-23 WO claimed
CN-118593483-A Application of indoleacrylic acid in preparation of diarrhea treatment drugs 西北农林科技大学 2024-09-06 CN disclosed
EP-4401714-A1 ORAL COMPOSITIONS WITH PLANT MATTER EXTRACTS AND METHODS OF MAKING THE SAME Nulixir Inc. (US) 2024-07-24 EP disclosed
EP-4401713-A1 ALIMENTARY-RELATED PARTICLES, PRODUCTION METHODS, AND PRODUCTION APPARATUS Nulixir Inc. (US) 2024-07-24 EP disclosed
WO-2023043854-A1 ALIMENTARY-RELATED PARTICLES, PRODUCTION METHODS, AND PRODUCTION APPARATUS Nulixir Inc. (US) 2023-03-23 WO disclosed
WO-2023043855-A1 ORAL COMPOSITIONS WITH PLANT MATTER EXTRACTS AND METHODS OF MAKING THE SAME Nulixir Inc. (US) 2023-03-23 WO disclosed